GGrantIndex
← Search

Developmental Funds

$390,453P30FY2019CANIH

University Of California At Davis, Davis CA

Investigators

Linked publications, trials & patents

Paper 39725713Paper 39620216Paper 39616300Paper 39488208Paper 39453739Paper 39440945Paper 39384967Paper 39383000Paper 39350111Paper 39345479Paper 39345391Paper 39257973Paper 39252929Paper 39217266Paper 39177582Paper 39168154Paper 39108503Paper 39103353Paper 39056190Paper 39046599Paper 39012466Paper 38990223Paper 38979288Paper 38969563Paper 38947002Paper 38885336Paper 38877132Paper 38865710Paper 38843382Paper 38826195Paper 38803393Paper 38798575Paper 38780011Trial NCT07304011Trial NCT07258446Trial NCT07209215Trial NCT07189195Trial NCT07145112Trial NCT06905509Trial NCT06854159Trial NCT06211335Trial NCT06178354Trial NCT06173362Trial NCT06173349Trial NCT06103682Trial NCT06103669Trial NCT06067776Trial NCT05967533Trial NCT05843448Trial NCT05600686Trial NCT05479578Trial NCT05110781Trial NCT05101356Trial NCT05052528Trial NCT04964505Trial NCT04905810Trial NCT04856189Trial NCT04716699Trial NCT04587687Trial NCT04578600Trial NCT04552704Trial NCT04450173Trial NCT04410302Trial NCT04186988Trial NCT04050085Trial NCT04030559Trial NCT03695250Trial NCT03359460Trial NCT03299088Trial NCT03164486Trial NCT03123978Trial NCT02997761Trial NCT02935205Trial NCT02823990Trial NCT02807805Trial NCT02569723Trial NCT02400814Trial NCT02364609Trial NCT02348255Trial NCT02339168Trial NCT02178241Trial NCT02077998Trial NCT01924260Trial NCT01923337Trial NCT01911507Trial NCT01008566Trial NCT00918645Trial NCT00810719Trial NCT00804310Trial NCT00795665Trial NCT00628654Trial NCT00467077Trial NCT00408499Trial NCT00390429Trial NCT00389922Trial NCT00388115Trial NCT00388089Trial NCT00387660Trial NCT00387322Trial NCT00376727

Abstract

PROJECT SUMMARY/ABSTRACT In the last funding cycle CCSG development funds were utilized for: A. Pilot projects: Twelve were funded solely by CCSG dollars (11 through a competitive call, 6 being joint projects between UCDCCC and Lawrence Livermore National Laboratory investigators) and seven were jointly funded with CCSG funds and matching funds from other colleges (four with the School of Veterinary Medicine and three with the College of Agricultural and Environmental Sciences). B. Contribution to three startup packages: Dr. Karen Kelly, MD (Associate Director for Clinical Research), William Murphy, PhD (Cancer Immunologist), and Mehrdad Abedi, MD (clinician scientist). C. Three staff investigators to expand imaging (John Boone, PhD), urothelial cancer (Chong-xian Pan, MD, PhD), and breast cancer research (Colleen Sweeney, PhD). D. A developing shared resource in Epidemiology. In this cycle, Developmental funds will be leveraged for: A. Pilot projects (2 per year). B. Faculty recruitment: Continued recruitment for Aiming Yu and startup package for two new strategic recruits. C. Research bench for the clinician scientists. D. Two staff investigators. E. A developing shared resource in Immune Monitoring

View original record on NIH RePORTER →